Abbott Laboratories (NYSE:ABT) Lowered to Buy Rating by StockNews.com
Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Wednesday. Several other equities analysts have also commented on the stock. Stifel Nicolaus upped their price target on shares of Abbott Laboratories from $130.00 to $135.00 and gave […]
Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Wednesday. Several other equities analysts have also commented on the stock. Stifel Nicolaus upped their price target on shares of Abbott Laboratories from $130.00 to $135.00 and gave […]
